ICD-10-PCS Code	Code Description	FY 2016		FY 2017		FY 2018		FY 2019		
		Frequency 	Approved as a New Technology? 	Frequency 	Approved as a New Technology? 	Frequency 	Approved as a New Technology? 	Frequency 	Approved as a New Technology? 	Total Frequency Procedure Code Reported
X2C0361	"Extirpation of matter from coronary artery, one artery using orbital atherectomy technology, percutaneous approach, new technology group 1"	"1,086"	NO	1574	NO	1787	NO	2002	NO	"6,446"
X2C1361	"Extirpation of matter from coronary artery, two arteries using orbital atherectomy technology, percutaneous approach, new technology group 1"	258	NO	264	NO	272	NO	272	NO	"1,066"
X2C2361	"Extirpation of matter from coronary artery, three arteries using orbital atherectomy technology, percutaneous approach, new technology group 1"	41	NO	33	NO	44	NO	36	NO	154
X2C3361	"Extirpation of matter from coronary artery, four or more arteries using orbital atherectomy technology, percutaneous approach, new technology group 1"	9	NO	0	NO	1	NO	2	NO	12
XR2G021	"Monitoring of right knee joint using intraoperative knee replacement sensor, open approach, new technology group 1"	858	NO	1135	NO	886	NO	887	NO	"3,766"
XR2H021	"Monitoring of left knee joint using intraoperative knee replacement sensor, open approach, new technology group 1"	796	NO	1093	NO	864	NO	818	NO	"3,571"
XW03321	"Introduction of ceftazidime-avibactam anti-infective into peripheral vein, percutaneous approach, new technology group 1"	48	NO	47	NO	62	NO	55	NO	212
XW03331	"Introduction of idarucizumab, dabigatran reversal agent into peripheral vein, percutaneous approach, new technology group 1"	13	NO	102	YES	102	YES	103	NO	320
XW03341	"Introduction of isavuconazole anti-infective into peripheral vein, percutaneous approach, new technology group 1"	5	NO	8	NO	14	NO	23	NO	50
XW03351	"Introduction of blinatumomab antineoplastic immunotherapy into peripheral vein, percutaneous approach, new technology group 1"	45	YES	43	YES	46	NO	61	NO	195
XW04321	"Introduction of ceftazidime-avibactam anti-infective into central vein, percutaneous approach, new technology group 1"	6	NO	7	NO	9	NO	12	NO	34
XW04331	"Introduction of idarucizumab, dabigatran reversal agent into central vein, percutaneous approach, new technology group 1"	0	NO	9	YES	12	YES	13	NO	34
XW04341	"Introduction of isavuconazole anti-infective into central vein, percutaneous approach, new technology group 1"	2	NO	3	NO	10	NO	9	NO	24
XW04351	"Introduction of blinatumomab antineoplastic immunotherapy into central vein, percutaneous approach, new technology group 1"	73	YES	104	YES	100	NO	114	NO	391
